Octavian Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Octavian Therapeutics General Information

Description

Developer of cannabinoid drugs and pharmaceutical products intended to combat inflammatory diseases, cancer, neurological disorders and pain management. The company develops prescription medicines targeting the endocannabinoid system using an ai-driven drug discovery platform and a library of over two thousand new chemical entities, enabling pharmaceutical companies to access novel small molecule treatments for debilitating neuropathic and visceral pain conditions.

Contact Information

Formerly Known As
Oxford Cannabinoid Technologies
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Prama House
  • 267 Banbury Road
  • Oxford OX2 7HT
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Prama House
  • 267 Banbury Road
  • Oxford OX2 7HT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Octavian Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 09-Jun-2026 Completed Bankruptcy: Liquidation
4. IPO 21-May-2021 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 28-Feb-2018 Completed Pre-Clinical Trials
2. Early Stage VC 15-Mar-2017 $12.3M $12.3M Completed Pre-Clinical Trials
1. University Spin-Out 10-Mar-2017 Completed Startup
To view Octavian Therapeutics’s complete valuation and funding history, request access »

Octavian Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cannabinoid drugs and pharmaceutical products intended to combat inflammatory diseases, cancer, neurologica
Drug Discovery
Oxford, United Kingdom
13 As of 2025

New York, NY
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Octavian Therapeutics Competitors (3)

One of Octavian Therapeutics’s 3 competitors is AXIM Biotechnologies, a Corporation company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AXIM Biotechnologies Corporation New York, NY
Jazz Pharmaceuticals Formerly VC-backed Dublin, Ireland
CV Sciences Corporation San Diego, CA
You’re viewing 3 of 3 competitors. Get the full list »

Octavian Therapeutics Patents

Octavian Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025149460-A1 Cannabinoid compositions Inactive 08-Jan-2024

Octavian Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Octavian Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Oxford University
To view Octavian Therapeutics’s complete investors history, request access »

Octavian Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Octavian Therapeutics’s complete esg history, request access »

Octavian Therapeutics FAQs

  • When was Octavian Therapeutics founded?

    Octavian Therapeutics was founded in 2017.

  • Where is Octavian Therapeutics headquartered?

    Octavian Therapeutics is headquartered in Oxford, United Kingdom.

  • What is the size of Octavian Therapeutics?

    Octavian Therapeutics has 13 total employees.

  • What industry is Octavian Therapeutics in?

    Octavian Therapeutics’s primary industry is Drug Discovery.

  • Is Octavian Therapeutics a private or public company?

    Octavian Therapeutics is a Private company.

  • What is Octavian Therapeutics’s current revenue?

    The current revenue for Octavian Therapeutics is .

  • How much funding has Octavian Therapeutics raised over time?

    Octavian Therapeutics has raised $46M.

  • Who are Octavian Therapeutics’s investors?

    University of Oxford has invested in Octavian Therapeutics.

  • Who are Octavian Therapeutics’s competitors?

    AXIM Biotechnologies, Jazz Pharmaceuticals, and CV Sciences are competitors of Octavian Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process